Skip to main content
Figure 3 | Molecular Pain

Figure 3

From: Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain

Figure 3

During 8 months of diabetes, Western blotting (A) identified mild increasing levels of Iba1 (B), beginning at 3 months of diabetes, when compared to non-diabetic littermates. As well, phosphorylated p38 MAPK elevates during diabetes until 5 months of time (C). Sample protein blots are demonstrated in A from a total of 3 sample blots identified for each marker and each time point. Multiple ANOVA tests were performed in each case, with * indicating significant difference (p < 0.05) between diabetic and non-diabetic cohorts.

Back to article page